Skip to main content
HOWL filings

Corporate insider profile

Luke Evnin Filing Activity

Latest reported as Director of Werewolf Therapeutics, Inc. (HOWL).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,177,488.21
Latest transaction
Jul 7, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jul 7, 2026Werewolf Therapeutics, Inc. (HOWL)DirectorSale143,199$0.31$44,750
Jun 29, 2026Werewolf Therapeutics, Inc. (HOWL)DirectorSale157,084$0.30$47,125
Jun 9, 2026Werewolf Therapeutics, Inc. (HOWL)DirectorSale76,928$0.37$28,463